ID   NPC-KT
AC   CVCL_X204
DR   TOKU-E; 4071
DR   Wikidata; Q54930970
RX   PubMed=3008992;
RX   PubMed=6088881;
RX   PubMed=6318711;
RX   PubMed=24991015;
CC   Characteristics: Hybrid of an EBV-positive NPC cells from 74 year old Japanese female with Ad-AH cells.
CC   Doubling time: 24 hours (PubMed=6088881).
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by RNAseq.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X200 ! Ad-AH
CA   Hybrid cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 8
//
RX   PubMed=3008992;
RA   Takimoto T., Sato H., Ogura H., Miyawaki T., Glaser R.;
RT   "Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and
RT   A2L/AH) with Epstein-Barr virus and the relationship to the C3d
RT   receptor.";
RL   Cancer Res. 46:2541-2544(1986).
//
RX   PubMed=6088881; DOI=10.1093/jnci/73.3.711;
RA   Takimoto T., Ogura H., Ohno S., Umeda R., Hatano M.;
RT   "Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.";
RL   J. Natl. Cancer Inst. 73:711-715(1984).
//
RX   PubMed=6318711; DOI=10.1007/BF00454266;
RA   Takimoto T., Kamide M., Umeda R.;
RT   "Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen
RT   (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).";
RL   Arch. Otorhinolaryngol. 239:87-92(1984).
//
RX   PubMed=24991015; DOI=10.1128/JVI.01457-14;
RA   Strong M.J., Baddoo M., Nanbo A., Xu M., Puetter A., Lin Z.;
RT   "Comprehensive RNA-seq analysis reveals contamination of multiple
RT   nasopharyngeal carcinoma cell lines with HeLa cell genomes.";
RL   J. Virol. 88:10696-10704(2014).
//